A Trial of SAMe for Treatment-Resistant Bipolar Depression

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2008
S-adenosyl-L-methionine (SAMe) is a dietary supplement with antidepressant properties. SAMe\'s mechanism of action remains unclear, but it appears to be distinct from that of conventional antidepressants. The purpose of this study is to examine the effect of these properties on the mood of bipolar subjects with persistent major depression that has been unresponsive to standard pharmacotherapy.
Epistemonikos ID: 742835dc74d2b7258bd2dbcdcb73629cf11d22cf
First added on: May 05, 2024